Cons The capsules may be difficult to swallow for some people
DIG exhibited higher positive signal intensity compared to sICIs across the following PTs: myocarditis (ROR 2.221, IC 025 0.486, PT: 10028606), immune-mediated myocarditis (ROR 2.922, IC 025 0.610, PT: 10082606), adrenal insufficiency (ROR 2.503, IC 025 0.602, PT: 10001367), hyperthyroidism (ROR 1.872, IC 025 0.305, PT: 10020850), thyroiditis (ROR 2.669, IC 025 0.546, PT: 10043778), immune-mediated enterocolitis (ROR 3.948, IC 025 0.937, PT: 10078961), pyrexia (ROR 1.570, IC 025 0.290, PT: 10037660), hepatic function abnormality (ROR 2.582, IC 025 0.591, PT: 10019670), hepatitis (ROR 2.705, IC 025 0.637, PT: 10019717), liver disorder (ROR 2.718, IC 025 0.646, PT: 10024670), immune-mediated hepatitis (ROR 5.504, IC 025 0.994, PT: 10078962), immune-mediated liver disorder (ROR 5.322, IC 025 0.966, PT: 10083521), cytokine release syndrome (ROR 7.650, IC 025 1.103, PT: 10052015), autoimmune diseases (ROR 1.754, IC 025 0.275, PT: 10061664), sepsis (ROR 1.414, IC 025 0.062, PT: 10040047), diabetic ketoacidosis (ROR 2.294, IC 025 0.472, PT: 10012671), type 1 diabetes mellitus (ROR 2.421, IC 025 0.508, PT: 10067584), arthritis (ROR 1.562, IC 025 0.113, PT: 10003246), myositis (ROR 2.204, IC 025 0.412, PT: 10028653), and acute kidney injury (ROR 1.708, IC 025 0.264, PT: 10069339)
These foods are rich in glutathione precursors like sulfur, cysteine, and selenium, or provide nutrients that protect existing glutathione from damage
The condition is often associated with intestinal dysbiosis, characterized by a decrease in beneficial bacteria such as Bifidobacteria, and an increase in potentially harmful bacteria like Enterococcus (132)
The peptide will migrate to the injury site from nearby subcutaneous tissue
